FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3132581044> ?p ?o ?g. }

• W3132581044 endingPage "29" @default.
• W3132581044 startingPage "PS8" @default.
• W3132581044 abstract "Abstract Background: Pathogenic factors embedded in the germline genome are widely recognized as being crucial to breast cancer development. However, current knowledge is either concentrated on the pathogenic variants of a few individual genes or SNPs distributed sparsely across the genome in non-coding regions. Methods: We developed a multi-layered framework, DAGG, which converts somatic mutations or germline rare coding variants (gRCVs) into a functional spectrum of dozens of cellular functions and signaling pathways to identify potential pathogenic factors.Findings: We analyzed whole-exome sequencing (WES) data of 726 germline DNA samples and 169 breast tumor DNA samples from breast cancer patients with various pathological types and cancer-free female subjects, we found that germline pathogens of breast cancers were (1) mainly distributed in HER2-negative subtypes, and (2) involved Her2 signaling pathway activation and immune suppression. These computational discoveries were experimentally validated and can provide digital features to explain the germline differences between diseased and healthy genome (AUC = 0.76). Furthermore, an individual’s risk for breast cancer can be estimated by calculating the combined effects of these identified germline pathogens. Carriers of BRCA1/2 pathogenic variants were found to have a significantly higher average risk (p = 0.02). Interpretation: The results demonstrated that the identified pathogenic mechanisms by DAGG were compatible with our current understanding of the causes of breast cancer. Moreover, DAGG provides improved performance over currently used polygenic risk score method of measuring complex disease risks. Our framework promises possible future applications for the prevention, diagnosis, and treatment of breast cancer. Citation Format: Mei Yang, Yanhui Fan, Zhi-Yong Wu, Zhendong Feng, Qiangzu Zhang, Shunhua Han, Zhonghai Zhang, Xu Li, Yiqing Xue, Xiaoling Li, Meixia Hu, Jieqing Li, Weiping Li, Hongfei Gao, Ciqiu Yang, Chunming Zhang, Liulu Zhang, Teng Zhu, Minyi Cheng, Fei Ji, Juntao Xu, Hening Cui, Guangming Tan, Michael Q Zhang, Changhong Liang, Zaiyi Liu, You-Qiang Song, Gang Niu, Kun Wang. Rare variants in the germline genome holistically determine receptor-independent Her2 signaling pathway activation and immune suppression, shaping pathological type and risk of HER2-negative breast cancer [abstract]. In: Proceedings of the 2020 San Antonio Breast Cancer Virtual Symposium; 2020 Dec 8-11; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2021;81(4 Suppl):Abstract nr PS8-29." @default.
• W3132581044 created "2021-03-01" @default.
• W3132581044 creator A5005781705 @default.
• W3132581044 creator A5006084923 @default.
• W3132581044 creator A5006750799 @default.
• W3132581044 creator A5007767807 @default.
• W3132581044 creator A5030691366 @default.
• W3132581044 creator A5032162374 @default.
• W3132581044 creator A5034733312 @default.
• W3132581044 creator A5037473789 @default.
• W3132581044 creator A5038742363 @default.
• W3132581044 creator A5039729883 @default.
• W3132581044 creator A5041893674 @default.
• W3132581044 creator A5045000339 @default.
• W3132581044 creator A5045873809 @default.
• W3132581044 creator A5047457258 @default.
• W3132581044 creator A5052047680 @default.
• W3132581044 creator A5052217154 @default.
• W3132581044 creator A5052594077 @default.
• W3132581044 creator A5053529978 @default.
• W3132581044 creator A5058814283 @default.
• W3132581044 creator A5060120199 @default.
• W3132581044 creator A5060367767 @default.
• W3132581044 creator A5060667885 @default.
• W3132581044 creator A5068190515 @default.
• W3132581044 creator A5069349208 @default.
• W3132581044 creator A5081917774 @default.
• W3132581044 creator A5082502249 @default.
• W3132581044 creator A5084018016 @default.
• W3132581044 creator A5088595510 @default.
• W3132581044 creator A5088880132 @default.
• W3132581044 date "2021-02-15" @default.
• W3132581044 modified "2023-10-17" @default.
• W3132581044 title "Abstract PS8-29: Rare variants in the germline genome holistically determine receptor-independent Her2 signaling pathway activation and immune suppression, shaping pathological type and risk of HER2-negative breast cancer" @default.
• W3132581044 doi "https://doi.org/10.1158/1538-7445.sabcs20-ps8-29" @default.
• W3132581044 hasPublicationYear "2021" @default.
• W3132581044 type Work @default.
• W3132581044 sameAs 3132581044 @default.
• W3132581044 citedByCount "0" @default.
• W3132581044 crossrefType "journal-article" @default.
• W3132581044 hasAuthorship W3132581044A5005781705 @default.
• W3132581044 hasAuthorship W3132581044A5006084923 @default.
• W3132581044 hasAuthorship W3132581044A5006750799 @default.
• W3132581044 hasAuthorship W3132581044A5007767807 @default.
• W3132581044 hasAuthorship W3132581044A5030691366 @default.
• W3132581044 hasAuthorship W3132581044A5032162374 @default.
• W3132581044 hasAuthorship W3132581044A5034733312 @default.
• W3132581044 hasAuthorship W3132581044A5037473789 @default.
• W3132581044 hasAuthorship W3132581044A5038742363 @default.
• W3132581044 hasAuthorship W3132581044A5039729883 @default.
• W3132581044 hasAuthorship W3132581044A5041893674 @default.
• W3132581044 hasAuthorship W3132581044A5045000339 @default.
• W3132581044 hasAuthorship W3132581044A5045873809 @default.
• W3132581044 hasAuthorship W3132581044A5047457258 @default.
• W3132581044 hasAuthorship W3132581044A5052047680 @default.
• W3132581044 hasAuthorship W3132581044A5052217154 @default.
• W3132581044 hasAuthorship W3132581044A5052594077 @default.
• W3132581044 hasAuthorship W3132581044A5053529978 @default.
• W3132581044 hasAuthorship W3132581044A5058814283 @default.
• W3132581044 hasAuthorship W3132581044A5060120199 @default.
• W3132581044 hasAuthorship W3132581044A5060367767 @default.
• W3132581044 hasAuthorship W3132581044A5060667885 @default.
• W3132581044 hasAuthorship W3132581044A5068190515 @default.
• W3132581044 hasAuthorship W3132581044A5069349208 @default.
• W3132581044 hasAuthorship W3132581044A5081917774 @default.
• W3132581044 hasAuthorship W3132581044A5082502249 @default.
• W3132581044 hasAuthorship W3132581044A5084018016 @default.
• W3132581044 hasAuthorship W3132581044A5088595510 @default.
• W3132581044 hasAuthorship W3132581044A5088880132 @default.
• W3132581044 hasConcept C104317684 @default.
• W3132581044 hasConcept C10590036 @default.
• W3132581044 hasConcept C106208931 @default.
• W3132581044 hasConcept C109825262 @default.
• W3132581044 hasConcept C121608353 @default.
• W3132581044 hasConcept C13514818 @default.
• W3132581044 hasConcept C135763542 @default.
• W3132581044 hasConcept C153209595 @default.
• W3132581044 hasConcept C16671776 @default.
• W3132581044 hasConcept C501734568 @default.
• W3132581044 hasConcept C502942594 @default.
• W3132581044 hasConcept C530470458 @default.
• W3132581044 hasConcept C54355233 @default.
• W3132581044 hasConcept C86803240 @default.
• W3132581044 hasConceptScore W3132581044C104317684 @default.
• W3132581044 hasConceptScore W3132581044C10590036 @default.
• W3132581044 hasConceptScore W3132581044C106208931 @default.
• W3132581044 hasConceptScore W3132581044C109825262 @default.
• W3132581044 hasConceptScore W3132581044C121608353 @default.
• W3132581044 hasConceptScore W3132581044C13514818 @default.
• W3132581044 hasConceptScore W3132581044C135763542 @default.
• W3132581044 hasConceptScore W3132581044C153209595 @default.
• W3132581044 hasConceptScore W3132581044C16671776 @default.
• W3132581044 hasConceptScore W3132581044C501734568 @default.
• W3132581044 hasConceptScore W3132581044C502942594 @default.
• W3132581044 hasConceptScore W3132581044C530470458 @default.
• W3132581044 hasConceptScore W3132581044C54355233 @default.
• W3132581044 hasConceptScore W3132581044C86803240 @default.
• W3132581044 hasIssue "4_Supplement" @default.

• next